Cargando…

Teriflunomide Preserves Neuronal Activity and Protects Mitochondria in Brain Slices Exposed to Oxidative Stress

Teriflunomide (TFN) limits relapses in relapsing–remitting multiple sclerosis (RRMS) by reducing lymphocytic proliferation through the inhibition of the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) and the subsequent modulation of de novo pyrimidine synthesis. Alterations of mitochondri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malla, Bimala, Liotta, Agustin, Bros, Helena, Ulshöfer, Rebecca, Paul, Friedemann, Hauser, Anja E., Niesner, Raluca, Infante-Duarte, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835718/ https://www.ncbi.nlm.nih.gov/pubmed/35163469 http://dx.doi.org/10.3390/ijms23031538

Ejemplares similares

Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
por: Malla, Bimala, et al.
Publicado: (2020)

Preventing Axonal Sodium Overload or Mitochondrial Calcium Uptake Protects Axonal Mitochondria from Oxidative Stress-Induced Alterations
por: Ulshöfer, Rebecca, et al.
Publicado: (2022)

Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation
por: Mothes, Ronja, et al.
Publicado: (2020)

Teriflunomide provides protective properties after oxygen-glucose-deprivation in hippocampal and cerebellar slice cultures
por: Wolters, Anna, et al.
Publicado: (2021)

Systematic Enzyme Mapping of Cellular Metabolism by Phasor-Analyzed Label-Free NAD(P)H Fluorescence Lifetime Imaging
por: Leben, Ruth, et al.
Publicado: (2019)

In the Right Place, at the Right Time: Spatiotemporal Conditions Determining Plasma Cell Survival and Function
por: Lindquist, Randall L., et al.
Publicado: (2019)

The chronically inflamed central nervous system provides niches for long-lived plasma cells
por: Pollok, Karolin, et al.
Publicado: (2017)

In good times and in bad: How plasma cells resolve stress for a life-long union with the bone marrow
por: Ulbricht, Carolin, et al.
Publicado: (2023)

Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE
por: Radbruch, Helena, et al.
Publicado: (2016)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide
por: Elrefaey, Ahmed, et al.
Publicado: (2023)

Two-Photon Excitation Spectra of Various Fluorescent Proteins within a Broad Excitation Range
por: Leben, Ruth, et al.
Publicado: (2022)

Phasor-Based Endogenous NAD(P)H Fluorescence Lifetime Imaging Unravels Specific Enzymatic Activity of Neutrophil Granulocytes Preceding NETosis
por: Leben, Ruth, et al.
Publicado: (2018)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

NAD(P)H Oxidase Activity in the Small Intestine Is Predominantly Found in Enterocytes, Not Professional Phagocytes
por: Lindquist, Randall L., et al.
Publicado: (2018)

Improvement of the Similarity Spectral Unmixing Approach for Multiplexed Two-Photon Imaging by Linear Dimension Reduction of the Mixing Matrix
por: Rakhymzhan, Asylkhan, et al.
Publicado: (2021)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2014)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023)

Neuropathy in multiple sclerosis patients treated with teriflunomide
por: Kilic, Ahmet Kasim, et al.
Publicado: (2023)

Intravital quantification reveals dynamic calcium concentration changes across B cell differentiation stages
por: Ulbricht, Carolin, et al.
Publicado: (2021)

Longitudinal Intravital Imaging of the Retina Reveals Long-term Dynamics of Immune Infiltration and Its Effects on the Glial Network in Experimental Autoimmune Uveoretinitis, without Evident Signs of Neuronal Dysfunction in the Ganglion Cell Layer
por: Bremer, Daniel, et al.
Publicado: (2016)

MR Elastography-Based Assessment of Matrix Remodeling at Lesion Sites Associated With Clinical Severity in a Model of Multiple Sclerosis
por: Wang, Shuangqing, et al.
Publicado: (2020)

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
por: Freedman, Mark S, et al.
Publicado: (2017)

In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy
por: Prinz, Christian, et al.
Publicado: (2021)

Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Ostendorf, Lennard, et al.
Publicado: (2019)

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients
por: Ostendorf, Lennard, et al.
Publicado: (2021)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Teriflunomide treatment reduces B cells in patients with MS
por: Gandoglia, Ilaria, et al.
Publicado: (2017)

Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
por: Ambrosius, Björn, et al.
Publicado: (2017)

COVID-19 in teriflunomide-treated patients with multiple sclerosis
por: Maghzi, Amir Hadi, et al.
Publicado: (2020)

Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2020)

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022)

Intravital FRET: Probing Cellular and Tissue Function in Vivo
por: Radbruch, Helena, et al.
Publicado: (2015)

Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1
por: Janssen, Antonia, et al.
Publicado: (2015)

Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy
por: Cohan, Stanley L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6lvncifj67gucu8dnf0qj4jfre